PL366800A1 - Tabletka zawierająca cetyryzynę i pseudoefedrynę - Google Patents

Tabletka zawierająca cetyryzynę i pseudoefedrynę

Info

Publication number: PL366800A1
Authority: PL; Poland
Prior art keywords: tablet; cetirizine; pseudoephedrine; combinations; treatment
Prior art date: 2001-06-28

Application number

PL02366800A

Other languages

English (en)

Other versions

PL206069B1 (pl

Inventor

Domenico Fanara

Anthony Guichaux

Monique Berwaer

Michel Deleers

Original Assignee

Ucb Farchim S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-28

Filing date

2002-06-10

Publication date

2005-02-07

2002-06-10 Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.

2005-02-07 Publication of PL366800A1 publication Critical patent/PL366800A1/pl

2010-06-30 Publication of PL206069B1 publication Critical patent/PL206069B1/pl

Links

ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 title 1
229960001803 cetirizine Drugs 0.000 title 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title 1
229960003908 pseudoephedrine Drugs 0.000 title 1
230000000172 allergic effect Effects 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

PL366800A 2001-06-28 2002-06-10 Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę PL206069B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30125001P	2001-06-28	2001-06-28
EP01115807		2001-06-28

Publications (2)

Publication Number	Publication Date
PL366800A1 true PL366800A1 (pl)	2005-02-07
PL206069B1 PL206069B1 (pl)	2010-06-30

Family

ID=56290291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL366800A PL206069B1 (pl)	2001-06-28	2002-06-10	Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę

Country Status (22)

Country	Link
EP (1)	EP1404304B1 (pl)
JP (1)	JP4041460B2 (pl)
KR (1)	KR100926410B1 (pl)
CN (1)	CN100490809C (pl)
AT (1)	ATE432068T1 (pl)
AU (1)	AU2002345024B2 (pl)
BR (1)	BR0210650A (pl)
CA (1)	CA2451519C (pl)
CZ (1)	CZ20033454A3 (pl)
DK (1)	DK1404304T3 (pl)
EE (1)	EE05357B1 (pl)
ES (1)	ES2324769T3 (pl)
HU (1)	HU229803B1 (pl)
MX (1)	MXPA03010430A (pl)
NZ (1)	NZ530289A (pl)
PL (1)	PL206069B1 (pl)
PT (1)	PT1404304E (pl)
RO (1)	RO122476B1 (pl)
RU (1)	RU2286784C2 (pl)
SI (1)	SI1404304T1 (pl)
SK (1)	SK287645B6 (pl)
WO (1)	WO2003002098A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL159287A0 (en) *	2001-06-28	2004-06-01	Ucb Farchim Sa	Tablet comprising cetirizine and pseudoephedrine
KR100698400B1 (ko)	2004-04-14	2007-03-23	이은주	탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
US20100172984A1 (en) *	2006-06-06	2010-07-08	Bijay Kumar Padhi	tablet dosage form comprising cetirizine and pseudoephedrine
PT2099442E (pt) *	2006-12-26	2015-02-10	Pharmacyclics Inc	Métodos de utilização de inibidores de histona desacetilase e monitorização de biomarcadores em terapia de combinação
US8439033B2 (en)	2007-10-09	2013-05-14	Microdose Therapeutx, Inc.	Inhalation device
ES2702753T3 (es)	2010-01-05	2019-03-05	Microdose Therapeutx Inc	Dispositivo de inhalación
KR101193495B1 (ko)	2010-02-01	2012-10-23	한미사이언스 주식회사	슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
MX352824B (es)	2010-06-16	2017-12-11	Inflammatory Response Res Inc	Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
CN102302497A (zh) *	2011-05-18	2012-01-04	天圣制药集团股份有限公司	一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko)	2011-07-15	2013-01-23	한미약품 주식회사	몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
NZ621221A (en)	2011-09-13	2016-07-29	Pharmacyclics Llc	Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
KR101372324B1 (ko) *	2012-02-09	2014-03-13	동국대학교 경주캠퍼스 산학협력단	알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
AU2014249531B2 (en)	2013-03-13	2018-11-29	IRR, Inc.	Use of levocetirizine and montelukast in the treatment of traumatic injury
EP2968309A4 (en)	2013-03-13	2016-08-31	Inflammatory Response Res Inc	USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY
RU2015134423A (ru)	2013-03-13	2017-04-26	Инфламматори Респонс Ресёрч, Инк.	Применение левоцитиризина и монтелукаста при лечении аутоиммуных расстройств
WO2016044095A1 (en)	2014-09-15	2016-03-24	Inflammatory Response Research, Inc.	Levocetirizine and montelukast in the treatment of inflammation mediated conditions
WO2016140630A1 (en)	2015-03-05	2016-09-09	PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş.	An effervescent composition comprising levocetirizine and pseudoephedrine
JP7703137B2 (ja) *	2020-02-03	2025-07-07	ケンビュー・ブランズ・エルエルシー	セチリジンを含む単層チュアブル錠剤
WO2021236518A1 (en)	2020-05-19	2021-11-25	IRR, Inc.	Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469009B1 (en) *	1996-04-08	2002-10-22	Ucb, S.A.	Pharmaceutical compositions for the treatment of rhinitis
EP0811374A1 (en) *	1996-05-29	1997-12-10	Pfizer Inc.	Combination dosage form comprising cetirizine and pseudoephedrine
BE1011045A3 (fr) *	1997-03-14	1999-04-06	Ucb Sa	Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) *	1999-09-24	2001-07-31	Ranbaxy Laboratories Limited	Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

2002
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko not_active Expired - Lifetime
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en not_active Ceased
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
- 2002-06-10 EE EEP200400005A patent/EE05357B1/xx unknown
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT1404304E (pt)	2009-06-26
CN1520285A (zh)	2004-08-11
RU2004101231A (ru)	2005-04-20
KR100926410B1 (ko)	2009-11-12
SK15502003A3 (sk)	2004-05-04
CN100490809C (zh)	2009-05-27
HUP0400386A3 (en)	2006-02-28
EP1404304A1 (en)	2004-04-07
EE05357B1 (et)	2010-12-15
EP1404304B1 (en)	2009-05-27
RU2286784C2 (ru)	2006-11-10
ATE432068T1 (de)	2009-06-15
CA2451519A1 (en)	2003-01-09
DK1404304T3 (da)	2009-07-13
JP4041460B2 (ja)	2008-01-30
RO122476B1 (ro)	2009-07-30
EE200400005A (et)	2004-02-16
BR0210650A (pt)	2004-10-05
HUP0400386A2 (hu)	2004-08-30
HU229803B1 (en)	2014-07-28
AU2002345024B2 (en)	2006-09-07
CA2451519C (en)	2007-11-06
ES2324769T3 (es)	2009-08-14
JP2004536829A (ja)	2004-12-09
PL206069B1 (pl)	2010-06-30
SI1404304T1 (sl)	2009-10-31
WO2003002098A1 (en)	2003-01-09
NZ530289A (en)	2004-11-26
SK287645B6 (sk)	2011-05-06
MXPA03010430A (es)	2004-12-06
CZ20033454A3 (cs)	2004-08-18
KR20040007756A (ko)	2004-01-24

Legal Events

Date	Code	Title	Description
2011-08-31	RECP	Rectifications of patent specification

Publication	Publication Date	Title
SI1404304T1 (sl)	2009-10-31	Tableta, obsegajoča cetirizin in psevdoefedrin
HUP0302845A3 (en)	2005-11-28	4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
ATE318590T1 (de)	2006-03-15	Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
PT1605956E (pt)	2016-03-09	Administração de capsaicinóides para o tratamento da osteoartrite
DE60225385D1 (de)	2008-04-17	Autentisches Document und dessen Herstellungsverfahren
WO2004006858A3 (en)	2004-04-29	Compounds, compositions, and methods employing same
AU2002334870B8 (en)	2003-04-22	Combinations for the treatment of immunoinflammatory disorders
CY1109238T1 (el)	2014-07-02	Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
AU2001266152A1 (en)	2002-01-02	Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
SG116507A1 (en)	2005-11-28	Pharmaceutical dosage form and method of making.
MXPA05012358A (es)	2006-02-02	Combinacion farmaceutica que comprende modafinilo y otra droga.
NO20033123D0 (no)	2003-07-08	Terapeutisk hinnedannende sammensetning og behandlingsplan derav
MXPA03007653A (es)	2003-12-04	Uso de lp82 para tratar trastornos hematopoyeticos.
AU2002224896A1 (en)	2002-06-11	Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
MXPA05005326A (es)	2005-10-10	Tableta que comprende efletirizina y pseudoefedrina.
IL158186A0 (en)	2004-03-28	Pharmaceutically active compounds and methods of use
AU2003255429A1 (en)	2004-03-03	Use of treosulfan and derivatives thereof for treating multiple sclerosis
HUP0102116A2 (hu)	2002-05-29	Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
SE0300830D0 (sv)	2003-03-26	New formulations and use thereof
WO2004024132A3 (de)	2004-06-10	Modulatoren der no-signalkaskade zur regulation der humanen endostatinexpression
AU8679801A (en)	2002-03-22	Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
AU2002301208A1 (en)	2003-06-12	Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders
HU0105291D0 (en)	2002-02-28	Pharmaceutical compositions for the treatment of indigestion and related diseases
AU2002238541A1 (en)	2002-08-19	Invasomes for the treatment of disease states, production and use thereof
UA42301A (uk)	2001-10-15	Засіб "камілаль" для лікування і профілактики проктологічних захворювань